ArticlePostepy dermatologii i alergologii2017

Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study.

Anna Sztafińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.